1984
DOI: 10.1097/00006231-198408000-00003
|View full text |Cite
|
Sign up to set email alerts
|

Physical approach for the reduction of dual radionuclide image subtraction artefacts in immunoscintigraphy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

1985
1985
2016
2016

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…In this series, it was in few cases interpreted as a positive finding. To our knowledge, this artefact has not been described earlier concerning parathyroid scintigraphy [40]. …”
Section: Discussionmentioning
confidence: 71%
“…In this series, it was in few cases interpreted as a positive finding. To our knowledge, this artefact has not been described earlier concerning parathyroid scintigraphy [40]. …”
Section: Discussionmentioning
confidence: 71%
“…Images of both the 131I-labeled antibody distribution and the 99mTc-blood pool were recorded using a large-field gamma-camera fitted with a high-energy (400 keV max) collimator. Without moving the patient 120 MBq n3mIn was administerad to label the blood transferrin [20]. After a further 5 rain an additional blood pool view was recorded.…”
Section: T/36 Antibody and Normal Immunoglobulinmentioning
confidence: 99%
“…Data were stored by computer in a matrix of either 64 x 64 or 128 x 128 elements. After normalization of count rates the images were subtracted as previously described [20].…”
Section: T/36 Antibody and Normal Immunoglobulinmentioning
confidence: 99%
“…The fi rst clinical use of this antibody was carried out in patients with colorectal cancer [ 1 ]. The imaging was technically demanding since the fi rst antibodies were radiolabelled with I-131 and the long survival of the antibody in the circulation necessitated the use of background subtraction employing Tc-99m-labelled human serum albumin [ 2 ]. The work with monoclonal antibodies progressed with Nottingham undertaking some of the fi rst in vivo studies using In-111 and Tc-99m-labelled antibodies [ 3 , 4 ] and published one of the fi rst studies of SPECT antibody imaging [ 5 ].…”
mentioning
confidence: 99%